Makoto Shintani

532 total citations
9 papers, 435 citations indexed

About

Makoto Shintani is a scholar working on Infectious Diseases, Virology and Molecular Biology. According to data from OpenAlex, Makoto Shintani has authored 9 papers receiving a total of 435 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 6 papers in Virology and 5 papers in Molecular Biology. Recurrent topics in Makoto Shintani's work include HIV/AIDS drug development and treatment (7 papers), HIV Research and Treatment (6 papers) and Chemical Synthesis and Analysis (2 papers). Makoto Shintani is often cited by papers focused on HIV/AIDS drug development and treatment (7 papers), HIV Research and Treatment (6 papers) and Chemical Synthesis and Analysis (2 papers). Makoto Shintani collaborates with scholars based in Japan and United States. Makoto Shintani's co-authors include Tsutomu Mimoto, Hideya Hayashi, Keizo Furuhashi, Takamasa Ueno, Yoshiaki Kiso, Ryohei Kato, Satoshi Nojima, Haruo Takaku, Junya Imai and Naoko Hattori and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Medicinal Chemistry and Applied Microbiology and Biotechnology.

In The Last Decade

Makoto Shintani

9 papers receiving 416 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Makoto Shintani Japan 8 195 181 156 132 82 9 435
Jay Trivedi United States 12 84 0.4× 61 0.3× 39 0.3× 65 0.5× 50 0.6× 20 277
Miao-Miao Horng United States 6 149 0.8× 166 0.9× 115 0.7× 261 2.0× 14 0.2× 8 495
Christer Sahlberg Sweden 14 209 1.1× 290 1.6× 221 1.4× 375 2.8× 20 0.2× 33 708
Giuliana Cuzzucoli Crucitti Italy 12 217 1.1× 244 1.3× 163 1.0× 201 1.5× 11 0.1× 20 499
Michael J. Bohanon United States 7 114 0.6× 127 0.7× 100 0.6× 109 0.8× 11 0.1× 8 327
Jeffrey A. Ruell United States 9 142 0.7× 57 0.3× 31 0.2× 51 0.4× 92 1.1× 12 428
Margarita C. Briñón Argentina 14 181 0.9× 209 1.2× 95 0.6× 101 0.8× 19 0.2× 48 452
Pascaline Fonteh South Africa 12 117 0.6× 55 0.3× 24 0.2× 87 0.7× 23 0.3× 29 411
Maya M. Makatini South Africa 12 128 0.7× 81 0.4× 56 0.4× 106 0.8× 17 0.2× 30 314
Cristina Gardelli Italy 14 202 1.0× 239 1.3× 125 0.8× 287 2.2× 25 0.3× 26 584

Countries citing papers authored by Makoto Shintani

Since Specialization
Citations

This map shows the geographic impact of Makoto Shintani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Makoto Shintani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Makoto Shintani more than expected).

Fields of papers citing papers by Makoto Shintani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Makoto Shintani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Makoto Shintani. The network helps show where Makoto Shintani may publish in the future.

Co-authorship network of co-authors of Makoto Shintani

This figure shows the co-authorship network connecting the top 25 collaborators of Makoto Shintani. A scholar is included among the top collaborators of Makoto Shintani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Makoto Shintani. Makoto Shintani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Mimoto, Tsutomu, et al.. (2007). Structure–activity relationships of novel HIV-1 protease inhibitors containing the 3-amino-2-chlorobenzoyl-allophenylnorstatine structure. Bioorganic & Medicinal Chemistry. 16(3). 1299–1308. 9 indexed citations
2.
Mimoto, Tsutomu, Satoshi Nojima, Haruo Takaku, et al.. (2003). Structure–activity and structure–metabolism relationships of HIV protease inhibitors containing the 3-hydroxy-2-methylbenzoyl-allophenylnorstatine structure. Bioorganic & Medicinal Chemistry. 12(1). 281–293. 23 indexed citations
3.
Mimoto, Tsutomu, Naoko Hattori, Haruo Takaku, et al.. (2000). Structure-Activity Relationship of Orally Potent Tripeptide-Based HIV Protease Inhibitors Containing Hydroxymethylcarbonyl Isostere.. Chemical and Pharmaceutical Bulletin. 48(9). 1310–1326. 37 indexed citations
4.
Yoshimura, Kazuhisa, Ryohei Kato, Keisuke Yusa, et al.. (1999). JE-2147: A dipeptide protease inhibitor (PI) that potently inhibits multi-PI-resistant HIV-1. Proceedings of the National Academy of Sciences. 96(15). 8675–8680. 87 indexed citations
5.
Wyvill, Kathleen M., Bach-Yen Nguyen, David Köhler, et al.. (1999). A phase I trial of the pharmacokinetics, toxicity, and activity of KNI-272, an inhibitor of HIV-1 protease, in patients with AIDS or symptomatic HIV infection. Antiviral Research. 41(1). 21–33. 7 indexed citations
6.
Mimoto, Tsutomu, Ryohei Kato, Haruo Takaku, et al.. (1999). Structure−Activity Relationship of Small-Sized HIV Protease Inhibitors Containing Allophenylnorstatine. Journal of Medicinal Chemistry. 42(10). 1789–1802. 60 indexed citations
7.
8.
Shintani, Makoto, et al.. (1990). Mechanism for the Enhancement Effect of Fatty Acids on the Percutaneous Absorption of Propranolol. Journal of Pharmaceutical Sciences. 79(12). 1065–1071. 90 indexed citations
9.
Furuhashi, Keizo, et al.. (1986). Effects of solvents on the production of epoxides by Nocardia corallina B-276. Applied Microbiology and Biotechnology. 23(3-4). 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jay Trivedi Breakdown of academic impact, for papers by Miao-Miao Horng Breakdown of academic impact, for papers by Christer Sahlberg Breakdown of academic impact, for papers by Giuliana Cuzzucoli Crucitti Breakdown of academic impact, for papers by Michael J. Bohanon Breakdown of academic impact, for papers by Jeffrey A. Ruell Breakdown of academic impact, for papers by Margarita C. Briñón Breakdown of academic impact, for papers by Pascaline Fonteh Breakdown of academic impact, for papers by Maya M. Makatini Breakdown of academic impact, for papers by Cristina Gardelli
Rankless by CCL
2026